EMLA PATCH 25 mg/ 25 mg


Patch 2s
scheduling status
S1
registration number
30/4/0478
What EMLA PATCH 25 mg/ 25 mg is and what it is used for
EMLA PATCH is indicated for: Topical anaesthesia of intact skin for minor procedures, such as needle insertion and superficial surgical treatment of localised lesions, where application of EMLA PATCH 1 hour before the procedure is feasible.
dosage
Adults One or more patch(es) are applied to the skin area(s) selected. Minimum application time: 1 hour. After a longer application time than 5 hours the anaesthesia decreases. Minor procedures, for example, needle insertion: EMLA PATCH should be applied to the skin area selected with a minimum application time of 1 hour. After a longer application time (more than 5 hours), the anaesthesia decreases. In the event of any allergic reaction developing, EMLA PATCH should be removed immediately. Paediatric population Paediatric population over 1 year of age One or more patch(es) are applied to the skin area(s) selected. Minimum application time: 1 hour. After a longer application time than 5 hours the anaesthesia decreases. Maximum dose for children aged 1 to 5 years is 10 patches. Maximum dose for children aged 6 to 11 years is 20 patches. Prior to curettage of mollusca in children with atopic dermatitis, an application time of 30 minutes is recommended. Infants aged 3 to 11 months The patch is applied to the skin area selected. Approximate application time: 1 hour. Not more than 2 patches should be applied at the same time. No clinically significant increase in methaemoglobin fractions has been observed following the application of 2 g EMLA cream for up to 4 hours. Term newborn infants and infants under 3 months of age The EMLA PATCH is applied to the selected skin area. Approximate application time: 1 hour, not more. A longer application time than 1 hour has not been documented. Not more than one EMLA PATCH should be applied at the same time. The size of the patch makes it less suitable for use on certain parts of the body in neonates and infants. Until further clinical data is available, EMLA PATCH should not be used in infants between 0 and 12 months of age receiving treatment with methaemoglobin inducing medicines.
how to take
Refer above.
What EMLA PATCH 25 mg/ 25 mg contains
Each EMLA PATCH contains 25 mg of lidocaine and 25 mg of prilocaine.
other ingredients
Carbomer, macrogolglycerol hydroxystearate, sodium hydroxide (for pH adjustment), purified water Adhesive: Acrylate.
Therapeutic classification
A4 Local anaesthetics.
© 2026 SAHPRA. ALL RIGHTS RESERVED